Corpas Genome,
Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders…
Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders…
https://www.nature.com/articles/gim201839
https://www.nature.com/articles/gim201839
Assessing the utility of whole-exome sequencing data reanalysis for diagnosis in Mendelian disorders and analyzing the cost-effec…